Загрузка...
Ibrexafungerp Demonstrates In Vitro Activity against Fluconazole-Resistant Candida auris and In Vivo Efficacy with Delayed Initiation of Therapy in an Experimental Model of Invasive Candidiasis
Candida auris is an emerging pathogen that has rapidly spread to many countries on multiple continents. Invasive infections caused by this species are associated with significant mortality, and treatment options are limited due to antifungal resistance. Ibrexafungerp is the first-in-class member of...
Сохранить в:
| Опубликовано в: : | Antimicrob Agents Chemother |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Microbiology
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8315906/ https://ncbi.nlm.nih.gov/pubmed/33753333 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02694-20 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|